Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Katey Einterz Owen currently holds 88,254 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katey Einterz Owen has been a net neutral trader of ADPT stock. They have purchased $0 and sold $0 worth of shares.
Katey Einterz Owen's most recent insider trade was on Mar 4, 2026, when they sold 15,625 shares at $0.00 per share.
Katey Einterz Owen serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Katey Einterz Owen holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Katey Einterz Owen has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Katey Einterz Owen was on Mar 4, 2026, when they purchased $0 worth of ADPT shares. This transaction involved 15,625 shares at N/A per share.
Katey Einterz Owen currently owns 88,254 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Katey Einterz Owen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Katey Einterz Owen has 6 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Katey Einterz Owen and 40,000+ other insiders.